BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 21796625)

  • 1. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
    Tang SN; Fu J; Nall D; Rodova M; Shankar S; Srivastava RK
    Int J Cancer; 2012 Jul; 131(1):30-40. PubMed ID: 21796625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
    Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
    Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.
    Li SH; Fu J; Watkins DN; Srivastava RK; Shankar S
    Mol Cell Biochem; 2013 Jan; 373(1-2):217-27. PubMed ID: 23129257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
    J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.
    Fu J; Rodova M; Roy SK; Sharma J; Singh KP; Srivastava RK; Shankar S
    Cancer Lett; 2013 Mar; 330(1):22-32. PubMed ID: 23200667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal.
    Rodova M; Fu J; Watkins DN; Srivastava RK; Shankar S
    PLoS One; 2012; 7(9):e46083. PubMed ID: 23029396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
    Sharma N; Nanta R; Sharma J; Gunewardena S; Singh KP; Shankar S; Srivastava RK
    Oncotarget; 2015 Oct; 6(31):32039-60. PubMed ID: 26451606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.
    Srivastava RK; Tang SN; Zhu W; Meeker D; Shankar S
    Front Biosci (Elite Ed); 2011 Jan; 3(2):515-28. PubMed ID: 21196331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
    Shankar S; Nall D; Tang SN; Meeker D; Passarini J; Sharma J; Srivastava RK
    PLoS One; 2011 Jan; 6(1):e16530. PubMed ID: 21304978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
    Fu J; Rodova M; Nanta R; Meeker D; Van Veldhuizen PJ; Srivastava RK; Shankar S
    Neuro Oncol; 2013 Jun; 15(6):691-706. PubMed ID: 23482671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.
    Tang SN; Singh C; Nall D; Meeker D; Shankar S; Srivastava RK
    J Mol Signal; 2010 Aug; 5():14. PubMed ID: 20718984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway.
    Verma RK; Yu W; Singh SP; Shankar S; Srivastava RK
    Nanomedicine; 2015 Nov; 11(8):2061-70. PubMed ID: 26199979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
    Verma RK; Yu W; Shrivastava A; Shankar S; Srivastava RK
    Sci Rep; 2016 Sep; 6():32743. PubMed ID: 27624879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
    Nanta R; Kumar D; Meeker D; Rodova M; Van Veldhuizen PJ; Shankar S; Srivastava RK
    Oncogenesis; 2013 Apr; 2(4):e42. PubMed ID: 23567619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway.
    Song L; Chen X; Wang P; Gao S; Qu C; Liu L
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):586-596. PubMed ID: 29697746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (‑)‑Epigallocatechin‑3‑gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway.
    Sun X; Song J; Li E; Geng H; Li Y; Yu D; Zhong C
    Oncol Rep; 2019 Jul; 42(1):425-435. PubMed ID: 31180522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms.
    Singh BN; Fu J; Srivastava RK; Shankar S
    PLoS One; 2011; 6(11):e27306. PubMed ID: 22087285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.
    Lin CH; Shen YA; Hung PH; Yu YB; Chen YJ
    BMC Complement Altern Med; 2012 Oct; 12():201. PubMed ID: 23110507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine.
    Wei R; Penso NEC; Hackman RM; Wang Y; Mackenzie GG
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
    PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.